• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

    2/21/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email

    4Q24 Sales of $329 million, down 14% versus prior year

    4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09

    4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year

    Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24

    Final insurance settlement proceeds related to 2019 PES supplier shutdown

    AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year.

    Full Year 2024 Summary

    • Sales down approximately 1% versus prior year driven by an approximately 2% decrease in volume primarily as a result of disclosed operational disruptions, partially offset by a 1% favorable net pricing impact
    • Net Income of $44.1 million, a decrease of $10.5 million versus the prior year
    • Adjusted EBITDA of $142.1 million, a decrease of $11.4 million versus the prior year
    • Adjusted EBITDA Margin of 9.4%, down 60 bps versus the prior year
    • Cash Flow from Operations of $135.4 million, an increase of $17.9 million versus the prior year
    • Capital Expenditures of $133.7 million, an increase of $26.3 million versus the prior year
    • Free Cash Flow of $1.7 million, a decrease of $8.5 million versus the prior year

    Summary full year 2024 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    FY 2024

     

    FY 2023

    Sales

    $1,517,557

     

    $1,533,599

    Net Income

    $44,149

     

    $54,623

    Diluted Earnings Per Share

    $1.62

     

    $1.95

    Adjusted Diluted Earnings Per Share (1)

    $1.96

     

    $2.14

    Adjusted EBITDA (1)

    142,116

     

    153,559

    Adjusted EBITDA Margin % (1)

    9.4%

     

    10.0%

    Cash Flow from Operations

    135,413

     

    117,550

    Free Cash Flow (1)(2)

    1,691

     

    10,173

    (1) See "Non-GAAP Measures" included in this press release for non-GAAP reconciliations

    (2) Net cash provided by operating activities less capital expenditures

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    FY 2024

     

    FY 2023 (1)

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    348,501

     

    23%

     

    $

    356,632

     

    23%

    Caprolactam

     

    276,303

     

    18%

     

     

    298,375

     

    20%

    Plant Nutrients

     

    458,152

     

    30%

     

     

    477,929

     

    31%

    Chemical Intermediates

     

    434,601

     

    29%

     

     

    400,663

     

    26%

    Total

    $

    1,517,557

     

    100%

     

    $

    1,533,599

     

    100%

    (1) Previously reported amounts have been updated for a reclassification to align more closely with the Company's current sales structure, resulting in an increase to Plant Nutrients and a decrease to Chemical Intermediates for FY 2023. Total revenue amounts were not impacted.

    "Our diverse portfolio, advantage of our business model and favorable industry dynamics - particularly in Plant Nutrients and Acetone - enabled us to successfully navigate a challenging operational year and deliver full year Adjusted EBITDA of $142 million, Adjusted Earnings Per Share of $1.96, and positive Free Cash Flow," said Erin Kane, president and CEO of AdvanSix. "We funded key growth and enterprise initiatives including our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program, returned cash to shareholders and maintained our healthy balance sheet. As we worked to deliver outcomes in the year, we also made significant progress on two key enterprise developments. First, we have successfully concluded our multi-year efforts to recover losses associated with the 2019 PES cumene supplier shutdown, including $5.3 million of insurance proceeds in the fourth quarter of 2024 and a final omnibus settlement of approximately $26 million in the first quarter of 2025. Second, we were pleased to be one of the first industrial companies to be recognized for our use of carbon capture technologies in our manufacturing process, claiming $9.7 million in 45Q tax credits for the 2018 and 2019 tax years, representing a meaningful medium- to long-term value driver as we continue to pursue these credits for subsequent periods."

    Fourth Quarter 2024 Summary

    • Sales down approximately 14% versus prior year driven by an approximately 16% decrease in volume primarily as a result of the extended plant turnaround, partially offset by 2% favorable impact of market-based pricing
    • Net Income of $0.4 million, an increase of $5.4 million versus the prior year
    • Adjusted EBITDA of $10.2 million, a decrease of $4.9 million versus the prior year
    • Adjusted EBITDA Margin of 3.1%, down 90 bps versus the prior year
    • Cash Flow from Operations of $64.2 million, an increase of $4.0 million versus the prior year
    • Capital Expenditures of $34.3 million, a decrease of $4.0 million versus the prior year
    • Free Cash Flow of $29.8 million, an increase of $8.0 million versus the prior year
    • $9.7 million in 45Q carbon capture tax credits for the 2018 and 2019 tax periods

    Summary fourth quarter 2024 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    4Q 2024

     

    4Q 2023

    Sales

    $329,063

     

    $382,208

    Net Income (Loss)

    352

     

    (5,082)

    Diluted Earnings Per Share

    $0.01

     

    ($0.19)

    Adjusted Diluted Earnings Per Share (1)

    $0.09

     

    ($0.10)

    Adjusted EBITDA (1)

    10,219

     

    15,099

    Adjusted EBITDA Margin % (1)

    3.1%

     

    4.0%

    Cash Flow from Operations

    64,165

     

    60,169

    Free Cash Flow (1)(2)

    29,816

     

    21,817

    (1) See "Non-GAAP Measures" included in this press release for non-GAAP reconciliations

    (2) Net cash provided by operating activities less capital expenditures

    Sales of $329 million in the quarter decreased approximately 14% versus the prior year. Sales volume decreased approximately 16% primarily driven by the delayed ramp to full operating rates following our fourth quarter 2024 planned plant turnaround. Market-based pricing was favorable by 2%, including continued strength in ammonium sulfate and acetone.

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    4Q 2024

     

    4Q 2023 (1)

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    67,172

     

    21%

     

    $

    78,251

     

    20%

    Caprolactam

     

    57,216

     

    17%

     

     

    82,508

     

    22%

    Plant Nutrients

     

    102,566

     

    31%

     

     

    119,119

     

    31%

    Chemical Intermediates

     

    102,109

     

    31%

     

     

    102,330

     

    27%

    Total

    $

    329,063

     

    100%

     

    $

    382,209

     

    100%

    (1) Previously reported amounts have been updated for a reclassification to align more closely with the Company's current sales structure, resulting in an increase to Plant Nutrients and a decrease to Chemical Intermediates for 4Q 2023. Total revenue amounts were not impacted.

    Adjusted EBITDA of $10.2 million in the quarter decreased $4.9 million versus the prior year primarily driven by the timing and impact of plant turnarounds, partially offset by changes in sales mix including lower export volumes, favorable pricing, net of raw material costs, and insurance claim proceeds.

    Adjusted earnings per share of $0.09 increased $0.19 versus the prior year driven primarily by the factors discussed above as well as $9.7 million in 45Q carbon capture tax credits for the 2018 and 2019 tax periods.

    Cash flow from operations of $64.2 million in the quarter increased $4.0 million versus the prior year primarily due to the favorable impact of changes in working capital, including higher ammonium sulfate pre-buy cash advances. Capital expenditures of $34.3 million in the quarter decreased $4.0 million versus the prior year.

    Outlook

    • Strong sulfur nutrition demand and tight North American ammonium sulfate supply expected to support sulfur premiums at or near high end of historical range; Anticipated higher raw material prices impacting fertilizer margins
    • Balanced global acetone supply and demand conditions expected to support industry spreads above cycle averages
    • Expect slower recovery off the trough for North American nylon industry conditions amid stable end market demand and increased domestic competitive pressure
    • Expect Capital Expenditures of $140 to $160 million in 2025, reflecting the planned progression of growth projects including our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program, and refined execution timing to address critical enterprise risk mitigation
    • Expect pre-tax income impact of plant turnarounds to be $25 to $30 million in 2025 versus approximately $58 million in 2024
    • Final omnibus settlement of approximately $26 million in 1Q25 related to PES supplier shutdown; Total of approximately $39 million aggregated insurance proceeds since 2019 event

    "While the year has been off to a slower start, particularly with approximately 25% of our portfolio exposed to domestic building and construction which remains subdued, we anticipate meaningful year-over-year earnings improvement in 2025. This is underpinned by operational and commercial excellence, with an expected approximately 10% sales volume increase for the year. We remain focused on improving through-cycle profitability, which requires us to drive productivity, optimize our regional and product sales mix and continue to promote the value proposition of our differentiated product portfolio. The broader macro backdrop for the industries we serve remains largely favorable overall with strong sulfur premiums supporting Plant Nutrients and a constructive global acetone supply and demand environment, which should serve as a counterbalance to an anticipated slower recovery across our Nylon Solutions business. We continue to protect our healthy balance sheet enabling our capital allocation framework to provide optionality for further value creation. We remain confident in the future prospects for AdvanSix and are committed to delivering sustainable long-term value to our shareholders," concluded Kane.

    Dividend

    The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on March 24, 2025 to stockholders of record as of the close of business on March 10, 2025.

    Conference Call Information

    AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix's fourth quarter 2024 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on February 21 until 12 noon ET on February 28 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 6798006.

    About AdvanSix

    AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people's lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

    Forward Looking Statements

    This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of uncertainty resulting from new or proposed regulatory, trade or other policies of the new U.S. presidential administration, and the conflict between Russia and Ukraine, the conflict in Israel and Gaza and related uncertainty in the surrounding area, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers' demand for our products and our suppliers' ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers' offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics and geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, as updated in subsequent reports filed with the SEC.

    Non-GAAP Financial Measures

    This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

    AdvanSix Inc.

    Consolidated Balance Sheets

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    December 31, 2024

     

    December 31, 2023

    ASSETS

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    19,564

     

     

    $

    29,768

     

    Accounts and other receivables – net

     

    145,673

     

     

     

    165,393

     

    Inventories – net

     

    212,386

     

     

     

    211,831

     

    Taxes receivable

     

    503

     

     

     

    1,434

     

    Other current assets

     

    8,990

     

     

     

    11,378

     

    Total current assets

     

    387,116

     

     

     

    419,804

     

     

     

     

     

    Property, plant and equipment – net

     

    917,858

     

     

     

    852,642

     

    Operating lease right-of-use assets

     

    153,438

     

     

     

    95,805

     

    Goodwill

     

    56,192

     

     

     

    56,192

     

    Intangible assets

     

    43,144

     

     

     

    46,193

     

    Other assets

     

    37,172

     

     

     

    25,384

     

    Total assets

    $

    1,594,920

     

     

    $

    1,496,020

     

     

     

     

     

    LIABILITIES

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    228,761

     

     

    $

    259,068

     

    Accrued liabilities

     

    47,264

     

     

     

    44,086

     

    Operating lease liabilities – short-term

     

    42,493

     

     

     

    32,053

     

    Income taxes payable

     

    1,047

     

     

     

    8,033

     

    Deferred income and customer advances

     

    37,538

     

     

     

    15,678

     

    Total current liabilities

     

    357,103

     

     

     

    358,918

     

     

     

     

     

    Deferred income taxes

     

    145,299

     

     

     

    151,059

     

    Operating lease liabilities – long-term

     

    111,400

     

     

     

    63,961

     

    Line of credit – long-term

     

    195,000

     

     

     

    170,000

     

    Postretirement benefit obligations

     

    —

     

     

     

    3,660

     

    Other liabilities

     

    11,468

     

     

     

    9,185

     

    Total liabilities

     

    820,270

     

     

     

    756,783

     

     

     

     

     

    STOCKHOLDERS' EQUITY

     

     

     

    Common stock, par value $0.01; 200,000,000 shares authorized; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024; 32,598,946 shares issued and 26,750,471 outstanding at December 31, 2023

     

    330

     

     

     

    326

     

    Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2024 and December 31, 2023

     

    —

     

     

     

    —

     

    Treasury stock at par (6,252,129 shares at December 31, 2024; 5,848,475 shares at December 31, 2023)

     

    (63

    )

     

     

    (58

    )

    Additional paid-in capital

     

    136,872

     

     

     

    138,046

     

    Retained earnings

     

    631,541

     

     

     

    605,067

     

    Accumulated other comprehensive income (loss)

     

    5,970

     

     

     

    (4,144

    )

    Total stockholders' equity

     

    774,650

     

     

     

    739,237

     

    Total liabilities and stockholders' equity

    $

    1,594,920

     

     

    $

    1,496,020

     

    AdvanSix Inc.

    Consolidated Statements of Operations

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

    2023

     

    Sales

    $

    329,063

     

     

    $

    382,208

     

     

    $

    1,517,557

     

    $

    1,533,599

     

     

     

     

     

     

     

     

     

    Costs, expenses and other:

     

     

     

     

     

     

     

    Costs of goods sold

     

    317,762

     

     

     

    363,667

     

     

     

    1,364,621

     

     

    1,368,511

     

    Selling, general and administrative expenses

     

    21,734

     

     

     

    24,828

     

     

     

    94,023

     

     

    95,538

     

    Interest expense, net

     

    2,174

     

     

     

    2,189

     

     

     

    11,311

     

     

    7,485

     

    Other non-operating (income) expense, net

     

    218

     

     

     

    (240

    )

     

     

    2,027

     

     

    (7,158

    )

    Total costs, expenses and other

     

    341,888

     

     

     

    390,444

     

     

     

    1,471,982

     

     

    1,464,376

     

     

     

     

     

     

     

     

     

    Income (loss) before taxes

     

    (12,825

    )

     

     

    (8,236

    )

     

     

    45,575

     

     

    69,223

     

    Income tax expense (benefit)

     

    (13,177

    )

     

     

    (3,154

    )

     

     

    1,426

     

     

    14,600

     

    Net income (loss)

    $

    352

     

     

    $

    (5,082

    )

     

    $

    44,149

     

    $

    54,623

     

     

     

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

     

     

     

    Basic

    $

    0.01

     

     

    $

    (0.19

    )

     

    $

    1.65

     

    $

    2.00

     

    Diluted

    $

    0.01

     

     

    $

    (0.19

    )

     

    $

    1.62

     

    $

    1.95

     

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    26,805,182

     

     

     

    26,911,754

     

     

     

    26,828,338

     

     

    27,302,254

     

    Diluted

     

    27,234,784

     

     

     

    26,911,754

     

     

     

    27,255,213

     

     

    28,007,630

     

    AdvanSix Inc.

    Consolidated Statements of Cash Flows

    (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Cash flows from operating activities:

     

     

     

     

     

     

     

    Net income (loss)

    $

    352

     

     

    $

    (5,082

    )

     

    $

    44,149

     

     

    $

    54,623

     

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    18,979

     

     

     

    18,673

     

     

     

    76,176

     

     

     

    73,010

     

    Loss on disposal of assets

     

    358

     

     

     

    342

     

     

     

    773

     

     

     

    1,281

     

    Deferred income taxes

     

    (12,629

    )

     

     

    (10,416

    )

     

     

    (8,991

    )

     

     

    (9,347

    )

    Stock-based compensation

     

    1,891

     

     

     

    2,473

     

     

     

    7,854

     

     

     

    8,313

     

    Amortization of deferred financing fees

     

    154

     

     

     

    154

     

     

     

    618

     

     

     

    618

     

    Operational asset adjustments

     

    —

     

     

     

    —

     

     

     

    1,200

     

     

     

    (4,472

    )

    Changes in assets and liabilities, net of business acquisitions:

     

     

     

     

     

     

     

    Accounts and other receivables

     

    3,342

     

     

     

    (20,696

    )

     

     

    18,411

     

     

     

    21,489

     

    Inventories

     

    1,048

     

     

     

    17,368

     

     

     

    (555

    )

     

     

    3,286

     

    Taxes receivable

     

    (128

    )

     

     

    64

     

     

     

    931

     

     

     

    8,337

     

    Accounts payable

     

    13,077

     

     

     

    29,367

     

     

     

    (30,610

    )

     

     

    (20,756

    )

    Income taxes payable

     

    612

     

     

     

    5,867

     

     

     

    (6,986

    )

     

     

    8,003

     

    Accrued liabilities

     

    (8,562

    )

     

     

    2,218

     

     

     

    2,426

     

     

     

    (5,569

    )

    Deferred income and customer advances

     

    36,021

     

     

     

    13,263

     

     

     

    21,860

     

     

     

    (18,752

    )

    Other assets and liabilities

     

    9,650

     

     

     

    6,574

     

     

     

    8,157

     

     

     

    (2,514

    )

    Net cash provided by operating activities

     

    64,165

     

     

     

    60,169

     

     

     

    135,413

     

     

     

    117,550

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

    Expenditures for property, plant and equipment

     

    (34,349

    )

     

     

    (38,352

    )

     

     

    (133,722

    )

     

     

    (107,377

    )

    Other investing activities

     

    (3,127

    )

     

     

    (1,116

    )

     

     

    (9,180

    )

     

     

    (3,520

    )

    Net cash used for investing activities

     

    (37,476

    )

     

     

    (39,468

    )

     

     

    (142,902

    )

     

     

    (110,897

    )

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

    Borrowings from line of credit

     

    94,500

     

     

     

    66,000

     

     

     

    406,000

     

     

     

    437,000

     

    Payments of line of credit

     

    (114,500

    )

     

     

    (66,000

    )

     

     

    (381,000

    )

     

     

    (382,000

    )

    Principal payments of finance leases

     

    (249

    )

     

     

    (240

    )

     

     

    (1,011

    )

     

     

    (938

    )

    Dividend payments

     

    (4,277

    )

     

     

    (4,303

    )

     

     

    (17,135

    )

     

     

    (16,657

    )

    Purchase of treasury stock

     

    (1

    )

     

     

    (8,500

    )

     

     

    (10,428

    )

     

     

    (46,151

    )

    Issuance of common stock

     

    104

     

     

     

    —

     

     

     

    859

     

     

     

    876

     

    Net cash used for financing activities

     

    (24,423

    )

     

     

    (13,043

    )

     

     

    (2,715

    )

     

     

    (7,870

    )

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    2,266

     

     

     

    7,658

     

     

     

    (10,204

    )

     

     

    (1,217

    )

    Cash and cash equivalents at beginning of period

     

    17,298

     

     

     

    22,110

     

     

     

    29,768

     

     

     

    30,985

     

    Cash and cash equivalents at the end of period

    $

    19,564

     

     

    $

    29,768

     

     

    $

    19,564

     

     

    $

    29,768

     

     

     

     

     

     

     

     

     

    Supplemental non-cash investing activities:

     

     

     

     

     

     

     

    Capital expenditures included in accounts payable

     

     

     

     

    $

    23,645

     

     

    $

    22,660

     

    AdvanSix Inc.

    Non-GAAP Measures

    (Dollars in thousands, except share and per share amounts)



    Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Net cash provided by operating activities

    $

    64,165

     

     

    $

    60,169

     

     

    $

    135,413

     

     

    $

    117,550

     

    Expenditures for property, plant and equipment

     

    (34,349

    )

     

     

    (38,352

    )

     

     

    (133,722

    )

     

     

    (107,377

    )

    Free cash flow (1)

    $

    29,816

     

     

    $

    21,817

     

     

    $

    1,691

     

     

    $

    10,173

     

     

     

     

     

     

     

     

     

    (1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment

     

    The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

    Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Net income (loss)

    $

    352

     

     

    $

    (5,082

    )

     

    $

    44,149

     

     

    $

    54,623

     

    Non-cash stock-based compensation

     

    1,891

     

     

     

    2,473

     

     

     

    7,854

     

     

     

    8,313

     

    Non-recurring, unusual or extraordinary (income) expense (2)

     

    —

     

     

     

    —

     

     

     

    1,200

     

     

     

    (4,472

    )

    Non-cash amortization from acquisitions

     

    531

     

     

     

    530

     

     

     

    2,126

     

     

     

    2,126

     

    Non-recurring M&A costs

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Income tax benefit relating to reconciling items

     

    (417

    )

     

     

    (504

    )

     

     

    (2,011

    )

     

     

    (661

    )

    Adjusted Net income (loss) (non-GAAP)

     

    2,357

     

     

     

    (2,583

    )

     

     

    53,318

     

     

     

    59,929

     

    Interest expense, net

     

    2,174

     

     

     

    2,189

     

     

     

    11,311

     

     

     

    7,485

     

    Income tax expense (benefit) - Adjusted

     

    (12,760

    )

     

     

    (2,650

    )

     

     

    3,437

     

     

     

    15,261

     

    Depreciation and amortization - Adjusted

     

    18,448

     

     

     

    18,143

     

     

     

    74,050

     

     

     

    70,884

     

    Adjusted EBITDA (non-GAAP)

    $

    10,219

     

     

    $

    15,099

     

     

    $

    142,116

     

     

    $

    153,559

     

     

     

     

     

     

     

     

     

    Sales

    $

    329,063

     

     

    $

    382,208

     

     

    $

    1,517,557

     

     

    $

    1,533,599

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA Margin (non-GAAP) (3)

     

    3.1

    %

     

     

    4.0

    %

     

     

    9.4

    %

     

     

    10.0

    %

     

     

     

     

     

     

     

     

    (2) 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A. alliance during the third quarter of 2023. During 2023, there were several transactions including the exit from the Oben Holding Group S.A. alliance, licensee exit of legacy technology and exit of certain low-margin oximes products that resulted in a $4.5 million net pre-tax loss.

    (3) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

    2024

     

     

    2023

     

     

    2024

     

    2023

    Net income (loss)

    $

    352

     

    $

    (5,082

    )

     

    $

    44,149

     

    $

    54,623

    Adjusted Net income (loss) (non-GAAP)

     

    2,357

     

     

    (2,583

    )

     

     

    53,318

     

     

    59,929

     

     

     

     

     

     

     

     

    Weighted-average number of common shares outstanding - basic

     

    26,805,182

     

     

    26,911,754

     

     

     

    26,828,338

     

     

    27,302,254

    Dilutive effect of equity awards and other stock-based holdings

     

    429,602

     

     

    —

     

     

     

    426,875

     

     

    705,376

    Weighted-average number of common shares outstanding - diluted

     

    27,234,784

     

     

    26,911,754

     

     

     

    27,255,213

     

     

    28,007,630

     

     

     

     

     

     

     

     

    EPS - Basic

    $

    0.01

     

    $

    (0.19

    )

     

    $

    1.65

     

    $

    2.00

    EPS - Diluted

    $

    0.01

     

    $

    (0.19

    )

     

    $

    1.62

     

    $

    1.95

    Adjusted EPS - Basic (non-GAAP)

    $

    0.09

     

    $

    (0.10

    )

     

    $

    1.99

     

    $

    2.20

    Adjusted EPS - Diluted (non-GAAP)

    $

    0.09

     

    $

    (0.10

    )

     

    $

    1.96

     

    $

    2.14

     

    The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company's management to evaluate the Company's operating performance, enhance a reader's understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company's operations.

    AdvanSix Inc.

    Appendix

    (Pre-tax income impact, Dollars in millions)



    Planned Plant Turnaround Schedule (4)

     

     

    1Q

    2Q

    3Q

    4Q

    FY

    Primary Unit

    Operation

    2017

    —

    ~$10

    ~$4

    ~$20

    ~$34

    Sulfuric Acid

    2018

    ~$2

    ~$10

    ~$30

    —

    ~$42

    Ammonia

    2019

    —

    ~$5

    ~$5

    ~$25

    ~$35

    Sulfuric Acid

    2020

    ~$2

    ~$7

    ~$20

    ~$2

    ~$31

    Ammonia

    2021

    ~$3

    ~$8

    —

    ~$18

    ~$29

    Sulfuric Acid

    2022

    ~$1

    ~$5

    ~$44(5)

    —

    ~$50

    Ammonia

    2023

    ~$2

    ~$1

    ~$27

    —

    ~$30

    Sulfuric Acid

    2024

    ~$5

    ~$3

    ~$3

    ~$47(6)

    ~$58

    Ammonia

    2025E

    ~$3

    ~$7

    —

    $15-$20

    $25-$30

    Sulfuric Acid

    (4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

    (5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income inclusive of fixed cost absorption, higher maintenance expense and lost sales.

    (6) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income inclusive of fixed cost absorption, higher maintenance expense, and lost sales

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250220498902/en/

    Media

    Janeen Lawlor

    (973) 526-1615

    [email protected]



    Investors

    Adam Kressel

    (973) 526-1700

    [email protected]

    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Counsel Kintiroglou Achilles B. sold $14,189 worth of shares (571 units at $24.85), decreasing direct ownership by 2% to 31,984 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/2/25 4:30:47 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Williams Patrick was granted 552 shares, increasing direct ownership by 2% to 34,193 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:42:44 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Newman Donald P was granted 977 shares, increasing direct ownership by 9% to 12,026 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:38:50 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    SEC Filings

    See more
    • SEC Form 144 filed by AdvanSix Inc.

      144 - AdvanSix Inc. (0001673985) (Subject)

      7/2/25 4:49:08 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form S-8 filed by AdvanSix Inc.

      S-8 - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:20:25 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:07:25 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdvanSix upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

      5/19/25 8:45:52 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

      4/7/25 8:48:39 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • Piper Sandler initiated coverage on AdvanSix with a new price target

      Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

      11/12/21 4:57:29 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      11/19/24 4:20:20 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    See more
    • AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

      9/12/24 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Donald P. Newman to Board of Directors

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

      8/19/24 4:30:00 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Farha Aslam to Board of Directors

      AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors. "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic prioritie

      12/14/21 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Financials

    Live finance-specific insights

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/13/24 4:55:58 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/9/24 9:58:57 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by AdvanSix Inc.

      SC 13G - AdvanSix Inc. (0001673985) (Subject)

      2/7/24 8:39:58 AM ET
      $ASIX
      Major Chemicals
      Industrials